Scarica l'app Stockscreener
7.91
7.70%
-0.66
Dopo l'orario di chiusura:
7.95
0.04
+0.51%
Precedente Chiudi:
$8.57
Aprire:
$8.43
Volume 24 ore:
1.21M
Relative Volume:
1.33
Capitalizzazione di mercato:
$522.46M
Reddito:
$301.79M
Utile/perdita netta:
$-43.42M
Rapporto P/E:
-11.80
EPS:
-0.6705
Flusso di cassa netto:
$-44.87M
1 W Prestazione:
-12.60%
1M Prestazione:
+4.49%
6M Prestazione:
+49.81%
1 anno Prestazione:
+7.62%
Intervallo 1D:
$7.75
$8.4499
Intervallo di 1 settimana:
$7.75
$9.31
Portata 52W:
$3.86
$9.31
Evolus Inc Stock (EOLS) Company Profile
Nome
Evolus Inc
Settore
Telefono
(949) 284-4555
Indirizzo
520 NEWPORT CENTER DRIVE, NEWPORT BEACH
Compare EOLS vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EOLS
Evolus Inc
|
7.91 | 566.05M | 301.79M | -43.42M | -44.87M | -0.6705 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
Evolus Inc Stock (EOLS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-06 | Downgrade | Needham | Buy → Hold |
| 2025-04-17 | Iniziato | BTIG Research | Buy |
| 2024-01-29 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-06-23 | Iniziato | Needham | Buy |
| 2022-05-12 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-20 | Aggiornamento | Truist | Hold → Buy |
| 2021-05-06 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-04-08 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-24 | Downgrade | Truist | Buy → Hold |
| 2020-07-07 | Downgrade | Mizuho | Buy → Neutral |
| 2020-02-06 | Ripresa | Mizuho | Buy |
| 2019-11-26 | Iniziato | SVB Leerink | Outperform |
| 2019-09-05 | Ripresa | Mizuho | Buy |
| 2019-06-28 | Iniziato | Wells Fargo | Market Perform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-02-14 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-29 | Iniziato | Stifel | Buy |
Mostra tutto
Evolus Inc Borsa (EOLS) Ultime notizie
(EOLS) Volatility Zones as Tactical Triggers - Stock Traders Daily
Evolus (EOLS) Notches A Profit Milestone While Betting Big On The Future - Yahoo Finance
Evolus Insider MOATAZEDI DAVID Sells 105,108 Shares at $9.04 Each (NASDAQ: EOLS) - Kalkine Media
Evolus president & CEO David Moatazedi sells $950,018 in shares By Investing.com - Investing.com South Africa
Evolus president & CEO David Moatazedi sells $950,018 in shares - Investing.com India
Evolus Officer Sold Shares Worth Over $950K - TradingView
Insider at Evolus (NASDAQ: EOLS) moves to sell nearly $1M in stock - Stock Titan
Evolus (EOLS) Advances 2.36% to $9.09, Holding Ground Above SupportRange Breakout - dars.gov.et
Evolus (EOLS) adds Soleus group as new 5.3% shareholder - Stock Titan
(EOLS) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2 - Eastern Progress
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet - Eastern Progress
Evolus (EOLS) Earnings Update: The EPS Result Is Above Expectation in the Current Update; Market Response: Shares Move Higher 2.22% on the DayEarnings Decline Risk - vinanet.vn
Evolus (EOLS) Results Check: EPS Prints Above Forecast in the Latest Reading; Trading Move - vinanet.vn
EOLS | Evolus, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move - vinanet.vn
Evolus (EOLS) Quarter in Focus: EPS Comes in Above Forecast on the Day; Share Move: The Share Price Adds 5.28% in the Current UpdatePretax Income Report - dars.gov.et
Evolus (EOLS) Closing Note: Records a 5.28% Increase to $8.18 in the Latest Session; the Price Remains Bounded by the Supplied Support and Resistance in the Available RecordBearish Sentiment - vinanet.vn
EOLS Q2 2026 Earnings: EPS Turns Positive, Delivering 156.82% Surprise vs. EstimatesCost Structure Review - vinanet.vn
August 2026's Leading Growth Companies With Insider Confidence - Sahm
Midday Stock Roundup: Mobix Labs Shares Fall 21% at Midday - ocbj.com
Renaissance Technologies LLC Lowers Stake in Evolus, Inc. $EOLS - marketbeat.com
Evolus, Inc. (EOLS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS - marketbeat.com
EOLS Q2 2026 Earnings: EPS Surprises to the Upside as Shares SlipReturn On Equity - vinanet.vn
Evolus (NASDAQ:EOLS) Reaches New 1-Year HighHere's What Happened - MarketBeat
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade - Yahoo Finance
Evolus: The Injectable Platform Is Becoming The Real Moat (NASDAQ:EOLS) - Seeking Alpha
EOLS Q2 2026 Earnings: EPS of $0.02 Beats Estimates by 156.8% as Profitability Inflection EmergesSpecial Dividend Alert - vinanet.vn
Trading Systems Reacting to (EOLS) Volatility - Stock Traders Daily
Evolus (NASDAQ:EOLS) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Needham Maintains Evolus(EOLS.US) With Hold Rating - moomoo.com
BTIG Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Evolus Inc (EOLS) Stock News Today - TradingKey
Evolus, Inc. (EOLS) Investor Outlook: Analyzing 97.93% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews
Stifel Maintains Evolus(EOLS.US) With Buy Rating, Maintains Target Price $17 - Moomoo
Evolus, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EOLS) 2026-08-06 - Seeking Alpha
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Su - GuruFocus
Earnings call transcript: Evolus tops revenue forecast in Q2 2026, shares rise - Investing.com UK
Evolus, Inc. Q2 2026 Financial Results: Revenue, Risks, and Key Business Updates - Minichart
Evolus Inc (EOLS) (Q2 2026) Earnings Call Highlights: Revenue Surges 21% and Adjusted EBITDA ... - Yahoo Finance
Evolus Q2 Earnings Call Highlights - MarketBeat
Is Evolus Inc (EOLS) Undervalued After Q2 Earnings Beat? EPS: -0 - GuruFocus
Evolus Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Evolus Q2 2026 slides: profitability streak continues, guidance raised - Investing.com
Evolus, Inc. Q2 2026: Revenue $84.08M, EPS ($0.12) — 10-Q Summary - TradingView
Evolus (EOLS) Releases Q2 2026 Earnings: Revenue Growth and Narrower Losses - Quiver Quantitative
Evolus (Nasdaq: EOLS) posts higher sales and manages sizable debt load - stocktitan.net
Evolus Q2 revenue rises 21%, lifts 2026 outlook - TradingView
Evolus Q2 2026 Earnings: Revenue Rises 21% as Adjusted EBITDA Stays Positive - TradingKey
Evolus (NASDAQ: EOLS) lifts 2026 guidance after Q2 revenue hits $84.1 million - Stock Titan
Evolus Inc Azioni (EOLS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):